Efficacy of Proton Beam Therapy in the Treatment of Ewing's Sarcoma of the Paranasal Sinuses and Anterior Skull Base

 

 Buy Article Permissions and Reprints

ABSTRACT

Ewing's sarcoma involving the sinonasal cavity and anterior skull base is very rare. The purpose of this article is to present our experience with two such cases, which were both treated with combined chemotherapy and proton beam radiation therapy. The patients were selected from a retrospective medical record analysis that was conducted of all patients who were diagnosed with Ewing's sarcoma of the sinonasal cavity at the Massachusetts Eye & Ear Infirmary/Massachusetts General Hospital Cranial Base Center from 2004 to 2008. One of the patients underwent pretreatment endoscopic subtotal resection to facilitate proton beam radiation therapy. Response to treatment was assessed, post-treatment endoscopic biopsies were performed to assure eradication of disease, and treatment complications were recorded. Both patients completed chemotherapy and proton beam radiation therapy without complication. One patient completed treatment in December 2006 and remains disease free. The second patient completed treatment in March 2007 and remains disease free. Both patients developed headaches accompanied by frontal sinus opacification after treatment that required endoscopic drainage. After endoscopic drainage, the opacification and symptoms resolved.

REFERENCES

• 1 Dahlin D C, Coventry M B, Scanlon P W. Ewing's sarcoma: a critical analysis of 165 cases.  J Bone Joint Surg Am. 1961;  43-A 185-192
  PubMedGoogle Scholar
• 2 Spjut H J, Dorfman H D, Fechner R E, Ackerman L V. Tumors of bone and cartilage. In: Atlas of Tumor Pathology. 2nd series, fasc 5. Washington, DC; Armed Forces Institute of Pathology 1971: 317
  Google Scholar
• 3 Siegal G P, Olivier W R, Reinus W R. Primary Ewing's sarcoma involving the bones of the head and neck.  Cancer. 1987;  60 2829-2840
  CrossrefPubMedGoogle Scholar
• 4 Fernandez C H, Lindberg R D, Sutox W W, Samuels M L. Localized Ewing's Sarcoma – treatment and results.  Cancer. 1974;  34(1) 143-148
  CrossrefPubMedGoogle Scholar
• 5 Strong L C, Herson J, Osborne B M, Sutow W W. Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcoma.  J Natl Cancer Inst. 1979;  62(6) 1401-1406
  PubMedGoogle Scholar
• 6 Hossfeld D K, Seeber S, Siemers E, Schmidt C G, Scherer E. Early results of combined modality therapy of patients with Ewing's sarcoma.  Recent Results Cancer Res. 1982;  80 124-127
  PubMedGoogle Scholar
• 7 Pontius K I, Sebek B A. Extraskeletal Ewing's sarcoma arising in the nasal fossa. Light- and electron-microscopic observations.  Am J Clin Pathol. 1981;  75(3) 410-415
  PubMedGoogle Scholar
• 8 Woodruff G, Thorner P, Skarf B. Primary Ewing's sarcoma of the orbit presenting with visual loss.  Br J Ophthalmol. 1988;  72(10) 786-792
  CrossrefPubMedGoogle Scholar
• 9 Lane S, Ironside J W. Extra-skeletal Ewing's sarcoma of the nasal fossa.  J Laryngol Otol. 1990;  104(7) 570-573
  PubMedGoogle Scholar
• 10 Csokonai L V, Liktor B, Arato G, Helffrich F. Ewing's sarcoma in the nasal cavity.  Otolaryngol Head Neck Surg. 2001;  125(6) 665-667
  CrossrefPubMedGoogle Scholar
• 11 Aferzon M, Wood W E, Powell J R. Ewing's sarcoma of the ethmoid sinus.  Otolaryngol Head Neck Surg. 2003;  128(6) 897-901
  CrossrefPubMedGoogle Scholar
• 12 Windfuhr J P. Primitive neuroectodermal tumor of the head and neck: incidence, diagnosis, and management.  Ann Otol Rhinol Laryngol. 2004;  113(7) 533-543
  PubMedGoogle Scholar
• 13 Howarth K L, Khodaei I, Karkanevatos A, Clarke R W. A sinonasal primary Ewing's sarcoma.  Int J Pediatr Otorhinolaryngol. 2004;  68(2) 221-224
  CrossrefPubMedGoogle Scholar
• 14 Coskun B U, Cinar U, Savk H, Basak T, Dadas B. Isolated maxillary sinus Ewing's sarcoma.  Rhinology. 2005;  43(3) 225-228
  PubMedGoogle Scholar
• 15 Kawabata M, Yoshifuku K, Sagara Y, Kurono Y. Ewing's sarcoma/primitive neuroectodermal tumour occurring in the maxillary sinus.  Rhinology. 2008;  46(1) 75-78
  PubMedGoogle Scholar
• 16 Jaffe N, Traggis D, Salian S, Cassady J R. Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy.  Cancer. 1976;  38 1925-1930
  CrossrefPubMedGoogle Scholar
• 17 Rosen G, Caparros B, Nirenberg A et al.. Ewing's sarcoma: ten-year experience with adjuvant chemotherapy.  Cancer. 1981;  47 2204-2213
  CrossrefPubMedGoogle Scholar
• 18 Jurgens H, Exner U, Gadner H et al.. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial.  Cancer. 1988;  61 23-32
  CrossrefPubMedGoogle Scholar
• 19 Bacci G, Toni A, Avella M et al.. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy.  Cancer. 1989;  63 1477-1486
  CrossrefPubMedGoogle Scholar
• 20 Burgert E O, Nesbit M E, Garnsey L A et al.. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup Study IESS-II.  J Clin Oncol. 1990;  8 1514-1524
  PubMedGoogle Scholar
• 21 Nesbit M E, Gehan E A, Burgert E O et al.. Multimodal therapy for the management of primary nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the first Intergroup Study.  J Clin Oncol. 1990;  8 1664-1674
  PubMedGoogle Scholar
• 22 Kinsella T J, Miser J S, Waller B et al.. Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy.  Int J Radiat Oncol Biol Phys. 1991;  20 389-395
  PubMedGoogle Scholar
• 23 Dunst J, Sauer R, Burgers M V et al.. Radiation therapy as local treatment in Ewing's sarcoma. Results of the cooperative Ewing's sarcoma studies CESS 81 and CESS 86.  Cancer. 1991;  67 2818-2825
  CrossrefPubMedGoogle Scholar
• 24 Hayes F A, Thompson E J, Meyer W H et al.. Therapy for localized Ewing's sarcoma of bone.  J Clin Oncol. 1989;  7 208-213
  PubMedGoogle Scholar
• 25 Bacci G, Campanacci M, Pagani P A. Adjuvant chemotherapy in the treatment of clinically localised Ewing's sarcoma.  J Bone Joint Surg Br. 1978;  60-B 567-574
  PubMedGoogle Scholar
• 26 Oberlin O, Habrand J L, Zucker J M et al.. No benefit of Ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.  J Clin Oncol. 1992;  10 1407-1412
  PubMedGoogle Scholar
• 27 Patel S, DeLaney T F. Advanced technology radiation therapy for bone sarcomas.  Cancer Control. 2008;  15(1) 21-37
  PubMedGoogle Scholar
• 28 Ewing J. Diffuse endothelioma of bone.  Proc N Y Pathol Soc. 1921;  21 17-24
  PubMedGoogle Scholar
• 29 Batsakis J G, Mackay B, El-Naggar A K. Ewing's sarcoma and peripheral primitive neuroectodermal tumor: an interim report.  Ann Otol Rhinol Laryngol. 1996;  105 838-843
  PubMedGoogle Scholar
• 30 Wood R E, Nortje C J, Hesseling P et al.. Ewing's tumor of the jaw.  Oral Surg Oral Med Oral Pathol. 1990;  69 120-127
  CrossrefPubMedGoogle Scholar
• 31 Yalcin S, Turoglu H T, Ozdamar S, Sadikoglu Y, Gurbuzer B, Yenici O. Ewing's tumor of the mandible.  Oral Surg Oral Med Oral Pathol. 1993;  76(3) 362-367
  CrossrefPubMedGoogle Scholar
• 32 Harman M, Kiroglu F, Kosem M et al.. Primary Ewing's sarcoma of the paranasal sinus with intracranial extension: Imaging features.  Dentomaxillofacial Radiol. 2003;  32(5) 343-346
  PubMedGoogle Scholar
• 33 Bridge R S, Rajaram V, Dehner L P, Pfeifer J D, Perry A. Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors.  Mod Pathol. 2006;  19 1-8
  CrossrefPubMedGoogle Scholar
• 34 Fiorillo A, Tranfa F, Canale G et al.. Primary Ewing's sarcoma of the maxilla, a rare and curable localization: report of two new cases, successfully treated by radiotherapy and systemic chemotherapy.  Cancer Lett. 1996;  103(2) 177-182
  CrossrefPubMedGoogle Scholar
• 35 Burgert Jr E O, Nesbit Jr M E, Gehan E A et al.. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup Study IESS-II.  J Clin Oncol. 1990;  8 1514-1524
  PubMedGoogle Scholar
• 36 Bacci G, Picci P, Ferrari S et al.. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: No benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase—results of two sequential studies.  Cancer. 1998;  82(6) 1174-1183
  CrossrefPubMedGoogle Scholar

Stacey Tutt GrayM.D. 

Department of Otology and Laryngology, Massachusetts Eye and Ear Infirmary

243 Charles Street, Boston, MA 02114

Email: stacey_gray@meei.harvard.edu